je.st
news
Investigational Brain Cancer Vaccine Produces Strong Immunological Response
2015-04-22 05:44:58| drugdiscoveryonline Home Page
A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in patients with recurrent or progressive malignant brain tumors, according to results of a phase I study conducted by Roswell Park Cancer Institute (RPCI) researchers.
Tags: strong
response
cancer
brain
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||